Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, April 28, 2022

Statin use in older adults linked to lower risk for parkinsonism

 Didn't your doctor already immediately prescribe statins post stroke for the recovery benefits?

Does your hospital have a protocol on statins? If not, your board of directors needs to be fired.

Statins.

tested in rats from 2003

http://Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke  

Simvastatin Attenuates Stroke-induced Splenic Atrophy and Lung Susceptibility to Spontaneous Bacterial Infection in Mice

Or,

Simvastatin attenuates axonal injury after experimental traumatic brain injury and promotes neurite outgrowth of primary cortical neurons   October 2012

tested in humans, March, 2011

http://www.medwirenews.com/39/91658/Stroke/Acute_statin_therapy_improves_survival_after_ischemic_stroke.html

And now lost even to the Wayback Machine

So I think this below is the actual research;

Association Between Acute Statin Therapy, Survival, and Improved Functional Outcome After Ischemic Stroke April 2011

 

Do you prefer your  doctor and hospital incompetence NOT KNOWING? OR NOT DOING?

The latest here:

 Statin use in older adults linked to lower risk for parkinsonism

Older adults had a 16% lower risk for developing parkinsonism after taking statins for 6 years compared with those not on statins, a report published in Neurology showed.

Shahram Oveisgharan, MD, assistant professor of neurological sciences at Rush Medical College in Chicago, and colleagues assessed 2,841 people (average age, 76 years) who did not have parkinsonism, 936 of whom were taking statins. Researchers monitored participants annually for an average of 6 years to check statin usage and signs of parkinsonism.

Source: Adobe Stock.
Source: Adobe Stock.

At the conclusion of the study, 1,432 people (50%) had developed signs of parkinsonism. Of the 936 who were taking statins, 418 people (45%) had developed parkinsonism compared with 1,014 of 1,905 (53%) who were not taking statins.

“Our results suggest people using statins may have a lower risk of parkinsonism, and that may be partly caused by the protective effect statins may have on arteries in the brain,” Oveisgharan said in a press release from the American Academy of Neurology. “Our results are exciting, because movement problems in older adults that come under the umbrella of parkinsonism are common, often debilitating and generally untreatable.”

Further, about 79% of participants on statins were taking moderate or high intensity doses. Those taking higher intensity doses had a 7% lower risk for developing parkinsonism vs. those taking low intensity doses.

Researchers also noted that 1,044 participants died during the study, and post-mortem examination of their brains revealed that those taking statins had 37% reduced odds of atherosclerosis compared with those who had not been taking statins.

“More research is needed, but statins could be a therapeutic option in the future to help reduce the effects of parkinsonism in the general population of older adults, not just people with high cholesterol or who are at risk for stroke,” Oveisgharan said. “At a minimum, our study suggests brain scans or vascular testing may be beneficial for older adults who show signs of parkinsonism but don’t have classic signs of Parkinson’s disease or do not respond to Parkinson’s disease medications.”

 

No comments:

Post a Comment